Amgen Inc News - 0R0T

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition PR...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 06 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Drugmakers agree to US government price talks amid pushback

Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesda ...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 02 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP 02 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 29 September 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

Adage Capital Partners LP Form 8.3/Form 38.5(a) - Horizon Therapeutics PLC

Adage Capital Partners LP 28 September 2023 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997...

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC 28 September 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF...

Adage Capital Partners LP Form 8.3 - Horizon Therapeutics PLC

Adage Capital Partners LP 27 September 2023 Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Amgen Inc (0R0T)

Professional-Grade Tools, for Individual Investors.

0R0T News

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Drugmakers agree to US government price talks amid pushback

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Adage Capital Partners LP Form 8.3/Form 38.5(a) - Horizon Therapeutics PLC

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Adage Capital Partners LP Form 8.3 - Horizon Therapeutics PLC

0R0T Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Amgen Inc (0R0T) News

Amgen Inc (0R0T)

Professional-Grade Tools, for Individual Investors.

0R0T News

Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Drugmakers agree to US government price talks amid pushback

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Adage Capital Partners LP Form 8.3/Form 38.5(a) - Horizon Therapeutics PLC

Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc

Adage Capital Partners LP Form 8.3 - Horizon Therapeutics PLC

0R0T Discussion

Your Recent History